7.5(top 2%)
impact factor
535(top 50%)
papers
10.8K(top 20%)
citations
49(top 10%)
h-index
7.8(top 2%)
impact factor
741
all documents
13.1K
doc citations
79(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Prevalence of Parkinson’s disease across North AmericaNpj Parkinson's Disease2018611
2The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?Npj Parkinson's Disease2017388
3Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammationNpj Parkinson's Disease2021315
4Current and projected future economic burden of Parkinson’s disease in the U.S.Npj Parkinson's Disease2020265
5Modeling Parkinson’s disease in midbrain-like organoidsNpj Parkinson's Disease2019204
6Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s diseaseNpj Parkinson's Disease2017189
7LRRK2 levels in immune cells are increased in Parkinson’s diseaseNpj Parkinson's Disease2017177
8Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s diseaseNpj Parkinson's Disease2018169
9Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s diseaseNpj Parkinson's Disease2016143
10Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogensNpj Parkinson's Disease2020140
11Parkinson’s disease: proteinopathy or lipidopathy?Npj Parkinson's Disease2020138
12COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedsideNpj Parkinson's Disease2020120
13Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive healthNpj Parkinson's Disease2018110
14Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control studyNpj Parkinson's Disease2015108
15Parkinson’s disease as a system-level disorderNpj Parkinson's Disease2016108
16NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s diseaseNpj Parkinson's Disease2018108
17Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s diseaseNpj Parkinson's Disease2018101
18The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidenceNpj Parkinson's Disease201799
19Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trialNpj Parkinson's Disease201798
20Cognitive decline in Parkinson’s disease: the complex pictureNpj Parkinson's Disease201696
21Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onsetNpj Parkinson's Disease201995
22Integrated molecular landscape of Parkinson’s diseaseNpj Parkinson's Disease201792
23Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s diseaseNpj Parkinson's Disease201892
24Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cellsNpj Parkinson's Disease202090
25Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiotaNpj Parkinson's Disease201986
26Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritabilityNpj Parkinson's Disease201983
27Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s diseaseNpj Parkinson's Disease202081
28Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson’s disease: a task-based fMRI studyNpj Parkinson's Disease201575
29Creation of a library of induced pluripotent stem cells from Parkinsonian patientsNpj Parkinson's Disease201674
30Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s diseaseNpj Parkinson's Disease202174
31Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans modelsNpj Parkinson's Disease201573
32Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s diseaseNpj Parkinson's Disease201870
33Sex specific cognitive differences in Parkinson diseaseNpj Parkinson's Disease202069
34The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic reviewNpj Parkinson's Disease201567
35Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trialNpj Parkinson's Disease201866
36Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of lifeNpj Parkinson's Disease202065
37Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s diseaseNpj Parkinson's Disease201763
38Parkinson’s progression prediction using machine learning and serum cytokinesNpj Parkinson's Disease201963
39The use of accelerometry as a tool to measure disturbed nocturnal sleep in Parkinson’s diseaseNpj Parkinson's Disease201862
40Fatigue in Parkinson’s disease: report from a multidisciplinary symposiumNpj Parkinson's Disease201661
41Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohortNpj Parkinson's Disease201861
42Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease modelNpj Parkinson's Disease201861
43Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s diseaseNpj Parkinson's Disease201760
44State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson diseaseNpj Parkinson's Disease201960
45Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activityNpj Parkinson's Disease201859
46Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregationNpj Parkinson's Disease201958
47The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey studyNpj Parkinson's Disease202158
48Dynamic control of the dopamine transporter in neurotransmission and homeostasisNpj Parkinson's Disease202158
49Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the roomNpj Parkinson's Disease201957
50How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative reviewNpj Parkinson's Disease202156